Excellent for single-focus disease. With multi-focal disease 60% have a chronic course, 30% achieve remission and mortality is up to 10%.
Langerhans cell histiocytosis
X-type histiocytosis
Sea-blue histiocytosis
Malignant histiocytosis
Crystal-storing histiocytosis
Non-X histiocytosis
Progressive nodular histiocytosis
Langerhans cell sarcoma